Developer docs
API playgroundTry for free, no card

Search company profiles

Supreme Cannabis

Full company profile

uuid0005wnj

Namestring
Supreme Cannabis
Websiteurl
supreme.ca
Company typeenum
Private
Founded yearint
1979
Short descriptiontext

Supreme Cannabis is a Toronto-based, delisted Canadian licensed cannabis producer that cultivated and sold medical and recreational cannabis under brands including 7ACRES and Blissco to provincial wholesalers and medical patients.

Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabis production, medical cannabis, recreational cannabis, cannabis cultivation, cannabis wholesale
Industry3 codes
1Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise)
CodeCRANAFAHPrimaryYes
2Medical Cannabis Dispensaries
CodeCRANAFABPrimaryNo
3Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
CodeCRANAFAGPrimaryNo
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Cannabis Cultivation and Production
Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Supreme Cannabis produces and sells medical and recreational cannabis products. Its core business is the licensed cultivation, manufacturing, and distribution of cannabis and cannabis derivatives to consumers and patients in the Canadian market.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Medical Cannabis
2Recreational Cannabis
No data
Peers10 records
1OrganiGram Holdings
TypeDirect peer
Description

Canadian licensed producer of medical and recreational cannabis; comparable mid-scale peer facing the same Canadian wholesale market dynamics, regulatory regime, and product-format mix.

2Canopy Growth Corporation
TypeDirect peer
Description

One of the largest Canadian licensed producers of medical and recreational cannabis; directly comparable to Supreme Cannabis as a federally regulated Canadian LP serving both medical patients and adult-use retail channels.

3Green Thumb Industries
TypeBroad incumbent
Description

U.S. multi-state cannabis operator with cultivation, processing, and retail; broader incumbent in the cannabis value chain with overlapping product formats (flower, vapes, edibles) but U.S.-focused, providing a read on operator economics at scale.

4Cronos Group
TypeDirect peer
Description

Canadian federally licensed producer with medical and adult-use operations; comparable as a TSX-listed cannabis cultivator pursuing brand-led growth in a similar regulatory environment.

5Aurora Cannabis Inc.
TypeDirect peer
Description

Major Canadian licensed producer of medical and recreational cannabis; comparable to Supreme Cannabis in production scale, dual medical/adult-use channels, and exposure to the same Canadian wholesale pricing dynamics.

6Sundial Growers
TypeEmerging player
Description

Canadian-originated cannabis producer (now privately held post-restructuring); relevant peer for Supreme Cannabis given parallel trajectory of delisting, restructuring, and refocusing around craft/premium positioning.

7Blissco Cannabis Corp.
TypeDirect peer
Description

Pre-acquisition British Columbia-based medical cannabis producer acquired by Supreme Cannabis in 2019; a former direct comparable and now a historical benchmark for Supreme's M&A strategy.

8Village Farms International
TypeEmerging player
Description

Canadian-controlled greenhouse operator with cannabis operations (Pure Sunfarms joint venture); comparable as a Canadian producer leveraging horticultural cultivation scale to compete in adult-use wholesale.

9HEXO Corp.
TypeDirect peer
Description

Canadian licensed producer of medical and recreational cannabis; comparable mid-cap Canadian LP that has undergone restructuring - a relevant peer given Supreme Cannabis's delisted and capital-constrained profile.

10Tilray Brands
TypeDirect peer
Description

Canadian-headquartered cannabis producer (formed via Tilray-Aphria merger) operating in medical and recreational markets globally; directly comparable as a federally licensed Canadian cultivator and brand operator.

Market position
Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Supreme Cannabis

Cannabis Cultivation and Productionsupreme.ca

Supreme Cannabis is a Toronto-based, delisted Canadian licensed cannabis producer that cultivated and sold medical and recreational cannabis under brands including 7ACRES and Blissco to provincial wholesalers and medical patients.

Supreme Cannabis firmographics

Firmographics
Name
Supreme Cannabis
Website
https://supreme.ca
Company type
Private
Founded year
1979
Headcount range
501–1,000 employees
Short description
Supreme Cannabis is a Toronto-based, delisted Canadian licensed cannabis producer that cultivated and sold medical and recreational cannabis under brands including 7ACRES and Blissco to provincial wholesalers and medical patients.
Ownership category
akta.pro rank

Supreme Cannabis industry classification

Industry
Product category
Cannabis Cultivation and Production
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH)
akta.pro secondary industries
Medical Cannabis Dispensaries (CRANAFAB), Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)

Keywords

  • Cannabis production
  • Medical cannabis
  • Recreational cannabis
  • Cannabis cultivation
  • Cannabis wholesale

Where Supreme Cannabis is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Markets served

Supreme Cannabis business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Supreme Cannabis product offering

Product offering

Core offering

Supreme Cannabis produces and sells medical and recreational cannabis products. Its core business is the licensed cultivation, manufacturing, and distribution of cannabis and cannabis derivatives to consumers and patients in the Canadian market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis
  • Recreational Cannabis

Companies that use Supreme Cannabis

Customer profile

Ideal customer profiles2 records

Supreme Cannabis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Supreme Cannabis competitors and assessment

Company assessment

Direct peers

  • OrganiGram Holdings: Canadian licensed producer of medical and recreational cannabis; comparable mid-scale peer facing the same Canadian wholesale market dynamics, regulatory regime, and product-format mix.
  • Canopy Growth Corporation: One of the largest Canadian licensed producers of medical and recreational cannabis; directly comparable to Supreme Cannabis as a federally regulated Canadian LP serving both medical patients and adult-use retail channels.
  • Cronos Group: Canadian federally licensed producer with medical and adult-use operations; comparable as a TSX-listed cannabis cultivator pursuing brand-led growth in a similar regulatory environment.
  • Aurora Cannabis Inc. Major Canadian licensed producer of medical and recreational cannabis; comparable to Supreme Cannabis in production scale, dual medical/adult-use channels, and exposure to the same Canadian wholesale pricing dynamics.
  • Blissco Cannabis Corp. Pre-acquisition British Columbia-based medical cannabis producer acquired by Supreme Cannabis in 2019; a former direct comparable and now a historical benchmark for Supreme's M&A strategy.
  • HEXO Corp. Canadian licensed producer of medical and recreational cannabis; comparable mid-cap Canadian LP that has undergone restructuring - a relevant peer given Supreme Cannabis's delisted and capital-constrained profile.
  • Tilray Brands: Canadian-headquartered cannabis producer (formed via Tilray-Aphria merger) operating in medical and recreational markets globally; directly comparable as a federally licensed Canadian cultivator and brand operator.

Broad incumbents

  • Green Thumb Industries: U.S. multi-state cannabis operator with cultivation, processing, and retail; broader incumbent in the cannabis value chain with overlapping product formats (flower, vapes, edibles) but U.S.-focused, providing a read on operator economics at scale.

Emerging players

  • Sundial Growers: Canadian-originated cannabis producer (now privately held post-restructuring); relevant peer for Supreme Cannabis given parallel trajectory of delisting, restructuring, and refocusing around craft/premium positioning.
  • Village Farms International: Canadian-controlled greenhouse operator with cannabis operations (Pure Sunfarms joint venture); comparable as a Canadian producer leveraging horticultural cultivation scale to compete in adult-use wholesale.

Market position

Customer concentration

Supreme Cannabis social profiles

Digital presence

Supreme Cannabis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Supreme Cannabis leadership team

Management profile

Number of profiles

Profiles4 records

Supreme Cannabis funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Supreme Cannabis M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Supreme Cannabis

What does Supreme Cannabis do?

Supreme Cannabis produces and sells medical and recreational cannabis products. Its core business is the licensed cultivation, manufacturing, and distribution of cannabis and cannabis derivatives to consumers and patients in the Canadian market.

When was Supreme Cannabis founded?

Supreme Cannabis was founded in 1979. It employs 501 to 1,000 people.

Where is Supreme Cannabis based?

Supreme Cannabis is headquartered in Toronto, Canada, in the North America region.

Who are Supreme Cannabis's main competitors?

Direct peers on record are OrganiGram Holdings, Canopy Growth Corporation, Cronos Group, Aurora Cannabis Inc., Blissco Cannabis Corp., HEXO Corp. and Tilray Brands. Green Thumb Industries is listed as a broad incumbent. Emerging players are Sundial Growers and Village Farms International.

Does Supreme Cannabis have an API?

No public API is recorded for Supreme Cannabis.

What industry is Supreme Cannabis in?

Supreme Cannabis's product category is Cannabis Cultivation and Production. Its primary akta.pro industry code is CRANAFAH, Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireRising Natural Wellness Momentum Fuels Cannabis MarketThe global cannabis market is entering a "Cannabis 3.0" phase characterized by wellness applications and mainstream product integration, with a market report estimating 2021 revenues at $19.89 billion and projecting 27% compound annual growth. BevCanna Enterprises Inc. has positioned itself as a leader through multiple acquisitions (Naturo Group, Pure Therapy, Embark Health) expanding from cannabis beverages into broader health and wellness, adding assets valued over $100 million including production facilities and proprietary formulations. Other major cannabis operators including Canopy Growth (acquired Supreme Cannabis), Tilray (launched medical edibles), Cresco Labs (four-state expansion), and Curaleaf (opened 109th dispensary) are similarly scaling operations as legislative support and consumer acceptance grow.PR NewswireThe Supreme Cannabis Company, Inc. Obtains Final Order for Arrangement with Canopy Growth CorporationThe Supreme Cannabis Company, Inc. has received final court approval from the Ontario Superior Court of Justice for its plan of arrangement with Canopy Growth Corporation. Under the deal, Canopy will acquire all outstanding Supreme shares at a rate of 0.01165872 of a Canopy share plus $0.0001 cash per share. Supreme shareholders approved the transaction on June 10, 2021, with closing expected on or about June 22, 2021.PR NewswireThe Supreme Cannabis Company, Inc. Announces Shareholder Approval of Arrangement with Canopy Growth CorporationSupreme Cannabis Company shareholders approved a plan of arrangement to acquire the company from Canopy Growth Corporation, with 81.05% of votes cast in favor. The transaction involves exchanging each Supreme share for 0.01165872 Canopy shares and $0.0001 in cash, pending final court approval expected by mid-June 2021. Closing is anticipated around June 17, 2021, subject to regulatory and third-party approvals.PR NewswireSupreme Cannabis Announces Financial Results for Q3 2021The Supreme Cannabis Company, Inc. reported Q3 2021 financial results for the three months ended March 31, 2021, posting positive Adjusted EBITDA of $0.5 million for the third consecutive quarter while net revenue declined to $13.6 million from $18.3 million in Q2 2021 due to COVID-19 lockdowns impacting recreational sales and regulatory delays affecting international medical shipments. Subsequent to quarter-end, Supreme Cannabis entered into a definitive arrangement agreement to be acquired by Canopy Growth Corporation, with Supreme Cannabis shareholders receiving a 66% premium based on closing prices as of April 7, 2021, subject to shareholder, regulatory, and court approvals expected to close in June 2021.PR NewswireSupreme Cannabis Schedules Third Quarter 2021 Financial Results Release and Conference CallSupreme Cannabis Company, Inc. announced it will release its third-quarter financial results for the period ended March 31, 2021, after market close on May 13, 2021. The company scheduled a conference call for May 14, 2021, to discuss these fiscal results with interested parties.PR NewswireCanopy Growth to Acquire The Supreme Cannabis CompanyCanopy Growth Corporation announced a definitive agreement to acquire The Supreme Cannabis Company, Inc. in a transaction valued at approximately $435 million on a fully-diluted basis. Under the arrangement, Supreme Cannabis shareholders will receive 0.01165872 of a Canopy common share plus $0.0001 in cash per share, representing a 66% premium based on April 7, 2021 closing prices. The transaction, expected to close by end of June 2021 pending shareholder, court, and regulatory approvals, will combine Canopy's market leadership with Supreme Cannabis' Top-10 position to create a pro forma Canadian recreational market share of 13.6%.PR NewswireSupreme Cannabis Announces Voting Results of the 2020 Annual General Meeting of ShareholdersThe Supreme Cannabis Company announced the voting results from its 2020 Annual General Meeting held on November 9, 2020, with all six board nominees elected by shareholders. KPMG LLP was reappointed as the company's auditor with 99.32% shareholder approval. The board elections received overwhelming support ranging from 97.54% to 98.94% approval.PR NewswireSupreme Cannabis Schedules First Quarter 2021 Financial Results Release and Conference CallThe Supreme Cannabis Company announced it will release its first quarter fiscal 2021 financial results for the three months ended September 30, 2020, after markets close on November 16, 2020, with a corresponding conference call scheduled for November 17, 2020. The announcement provides dial-in numbers and a webcast link for the earnings call, along with replay access details through December 17, 2020. This is a routine corporate disclosure scheduling notice typical for publicly traded companies.PR NewswireSupreme Cannabis Amends Credit FacilityThe Supreme Cannabis Company has entered into a credit facility amendment with its lenders, deferring financial covenants related to fixed charge coverage ratio and leverage by 12 months to March 31, 2022. The company agreed to a 75 basis point increase in its interest rate margin and removed its minimum restricted cash balance requirement, using that balance to repay a portion of the outstanding term loan which now stands at $57.2 million. The amendment reflects Supreme Cannabis' strategy to right-size its operations toward achieving profitability as a premium cannabis consumer packaged goods company.PR NewswireSupreme Cannabis Schedules Fourth Quarter and Year-end 2020 Financial Results Release and Conference CallSupreme Cannabis Company, Inc. announced that it will release its fourth-quarter and year-end financial results for the period ended June 30, 2020, after market close on September 24, 2020. The company is scheduled to host a conference call on September 25, 2020, to discuss these fiscal 2020 results with interested parties.